New heart pump aims to keep patients alive without major complications

NCT ID NCT01187368

Terminated Disease control Sponsor: Evaheart, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares a new heart pump (EVAHEART®2) to a current pump in 399 adults with severe heart failure. The goal is to see if the new pump helps people survive until a heart transplant or recover enough to have the pump removed, without suffering a disabling stroke or severe right heart failure. Participants will be followed for up to 24 months after implantation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

advanced heart failure heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE

Contacts and locations

Locations

Baylor College of Medicine

Houston, Texas, 77030, United States
Baylor Scott and White, Dallas

Dallas, Texas, 75246, United States
Methodist Hospital - San Antonio

San Antonio, Texas, 78229, United States
Penn State Health Milton S Hershey Medical Center

Hershey, Pennsylvania, 17033, United States
St. Vincent Hospital Indianapolis

Indianapolis, Indiana, 46260, United States
Tampa General Hospital

Tampa, Florida, 33606, United States
The Christ Hospital

Cincinnati, Ohio, 45219, United States
Tufts Medical Center

Boston, Massachusetts, 02111, United States
UF Health Shands Hospital

Gainesville, Florida, 32608, United States
University of Louisville

Louisville, Kentucky, 40202, United States
University of Virginia Medical Center

Charlottesville, Virginia, 22908, United States
University of Wisconsin-Madison

Madison, Wisconsin, 53792, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.